Type 2 Diabetes and Elevated Triglycerides

Type 2 Diabetes and Elevated Triglycerides

Aug 08, 2018 02:08 PM EDT - Author: Amber


A clinical research study is underway for those who have been diagnosed with Type 2 diabetes, have high Triglycerides, low HDL cholesterol “good cholesterol”, and at risk for future cardiovascular events.

The main goal of this study is to learn if a potential new medication can help prevent heart attacks and other heart-related conditions and reduce the level of triglycerides in the blood.

Triglycerides are a type of fat in your blood. If you take in more calories from food than your body needs, the blood converts those calories into Triglycerides. Triglycerides are stored in fat cells. High levels of Triglycerides can increase your chances of having heart disease.


This study will last about 5 years. All visits are conducted locally in Salt Lake City, Utah.

Benefits of Participating:

  • Receive $50 per visit.
  • Study medication provided at no cost to you.
  • No cost to participate.
  • No insurance needed.
  • Completely voluntary, no obligation to continue.

To Qualify, You Must:

  • Be over 18 years old
  • Be diagnosed with Type 2 Diabetes and currently be taking treatment.
  • Have been told that you have moderately high triglyceride levels.

To find out more call us at 801-363-7353 or submit the form below. By contacting us, you are in no way obligated to participate.  All information submitted is kept strictly confidential and is never shared or sold to third parties.



Get Involved!
First Name: *
Last Name: *
Email: *
What studies would you be interested in participating in? (Select all that apply)


Diabetes Type 2

High Blood Pressure



High Cholesterol


Heart Attack


Diabetes Type 1

Heart Disease

Weight Loss



Low Testosterone


We’re always adding new studies to our list, what other conditions do you have or would you be interested in joining a study for? (I.E. Fibromyalgia, etc.)
Medications you currently take (Optional):
How Did You Hear About Us?

Subscribe to OCR's Monthly Newsletter